318
views
1
recommends
+1 Recommend
2 collections
    3
    shares
       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Three-Component Solvent for the Treatment for COVID-19: Is the Data in Place for Clinical Trial?

      Preprint
      In review
      research-article
        1 , , 1 , 2
      UnisaRxiv
      UNISA Press
      COVID-19, treatment, protein, ethanol, alcohol
      Bookmark

            Abstract

            This letter outlines the potential use of a three-component solvent, with strong anti-viral properties, as an economical and efficient treatment of COVID-19. It focuses on the generation and delivery of the alcohol-based solvent as nanodroplets deep within a patients lungs to reduce the viral load and potentially reduce the impact of a bradykinin or cytokine storm. The treatment is considered for compassionate use where other methods are not available or will not work.

            Content

            Author and article information

            Journal
            UnisaRxiv
            UNISA Press
            26 January 2021
            Affiliations
            [1 ] Valdosta State University, USA
            [2 ] Forrest General Hospital and Hattiesburg Clinic, USA
            Article
            10.25159/UnisaRxiv/000003.v1
            dee890fe-6667-4a1e-aedf-8f83464e568b

            This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .


            The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
            Medicine
            COVID-19,treatment,protein,ethanol,alcohol

            Comments

            Comment on this article